Accredited CPD activity for General Practitioners on biosimilar medicines

A doctor looking at an image of a brain on a laptop

Accredited CPD Activity for General Practitioners

Biosimilar medicines: information for general practitioners

This activity addresses the following learning objectives using a combination of reading and active listening to video content:

Upon completion of this activity, participants will be able to:

  • Explain how biosimilar medicines contribute to the sustainability of the Australian healthcare system
  • Outline the clinical development and regulatory processes required prior to approval of biosimilar medicines
  • Explain to patients what a biosimilar medicine is, why it is different to a generic medicine, and their therapeutic equivalence to the reference biological product
  • Manage patient concerns and queries surrounding biosimilar medicines
  • Define the criteria that must be met in order to substitute a PBS-subsidised reference biological for a biosimilar medicine

This activity has been approved for two (2) CPD Activity points in the RACGP CPD 2020-2022 triennium.

Accreditation number: 187138.